April 2, 2026
Waters Kraus Paul & Siegel has once again earned recognition from the Chambers Spotlight Guide, marking the second consecutive year the firm has been honored for its reputation and expertise in product liability litigation.
Through the London-based organization’s rigorous and independent research process, Chambers and Partners is widely regarded as the gold standard for identifying law firms with exceptional capabilities and client results. For the second year in a row, Waters Kraus Paul & Siegel is the only Dallas-based firm recognized in this category.
The Chambers Spotlight regional guide highlights outstanding mid-sized firms with strong reputations in key practice areas, identifying firms that consistently deliver high-level results in complex matters.
This latest recognition follows another standout year for the firm across multiple practice areas, including several significant trial victories and litigation settlements.
Recent Results and Case Highlights
$12.75 Million Talc/Asbestos Exposure Verdict
March 2026: A Los Angeles County jury has returned a $12.75 million verdict on behalf of the family of a Los Angeles physician who died from mesothelioma cancer, finding that third-party cosmetic manufacturer Port Jervis Laboratories, Inc. (formerly Kolmar Laboratories) failed to warn about the dangers of asbestos exposure from its talc-based cosmetic products. Read more.
$7.25 Billion Monsanto Roundup Settlement Class Action
February 2026: WKPS joined a coalition of plaintiffs’ firms to help secure a landmark $7.25 billion class-action settlement with Monsanto related to Roundup litigation. Read more.
Mid-Trial Mesothelioma Settlement
December 2025: A confidential settlement was reached during trial after evidence and cross-examination pressure brought Reynolds metals to the table. Read more.
Whistleblower Client Assists in $13.6M FCA Healthcare Billing Fraud Recovery A December 2025: WKPS whistleblower client helped launched FCA litigation that led to a $13.6M settlement with an Austin-area pain management practice. Read more.
WKPS Clients Secure $2.8M Walgreens FCA Settlement
June 2025: WKPS whistleblower clients secured a $2.8M FCA settlement after allegations that Walgreens inflated drug prices for Medicaid programs. Read more.
$18.2M Qui Tam Settlement With CVS
March 2025: A former CVS pharmacist’s qui tam case led to an $18.2M settlement over alleged unsupported reimbursement claims. Read more.
About Waters Kraus Paul & Siegel
Waters Kraus Paul & Siegel is a national plaintiffs law firm devoted to helping families in personal injury and wrongful death cases involving asbestos and mesothelioma, benzene exposure, dangerous pharmaceuticals, medical devices, and birth defects caused by pesticides, toxic chemicals, opioid use, and semiconductor chip manufacturing. The law firm also represents plaintiffs in qui tam whistleblower matters and cases that uncover false claims submitted to the government, as well as commercial truck crashes and lawsuits against entities that fail to protect children from sexual abuse. Based in Dallas and with offices in Los Angeles and Moline, Illinois, Waters Kraus Paul & Siegel has represented families from all fifty states and many foreign countries, as well as foreign governments.
Our Results
Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.
A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.
Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.
That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win.
